Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin sodium Warfarin sodium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬1. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin potassium Warfarin potassium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬1. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
NQO1 1件: NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin Warfarin 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬1. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Complement and coagulation cascades 💬 22 genes, 45 drugs (DrugBank) and 52 diseases |
F10 1件: F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 6件: 46, 49, 56, 91, 210, 271 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Complement and coagulation cascades 💬 22 genes, 45 drugs (DrugBank) and 52 diseases |
F2 1件: F2 💬Complement and coagulation cascades
|
Dabigatran Dabigatran 💬Complement and coagulation cascades
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬5. Complement and coagulation cascades
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
F2 1件: F2 💬Coronavirus disease - COVID-19
|
Dabigatran Dabigatran 💬Coronavirus disease - COVID-19
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬6. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin sodium Warfarin sodium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬7. Fluid shear stress and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin potassium Warfarin potassium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬7. Fluid shear stress and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
NQO1 1件: NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin Warfarin 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬7. Fluid shear stress and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin sodium Warfarin sodium 💬Hepatocellular carcinoma
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬10. Hepatocellular carcinoma
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin potassium Warfarin potassium 💬Hepatocellular carcinoma
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬10. Hepatocellular carcinoma
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
NQO1 1件: NQO1 💬Hepatocellular carcinoma
|
Warfarin Warfarin 💬Hepatocellular carcinoma
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬10. Hepatocellular carcinoma
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
F2 1件: F2 💬Neuroactive ligand-receptor interaction
|
Dabigatran Dabigatran 💬Neuroactive ligand-receptor interaction
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬13. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
F2 1件: F2 💬Pathogenic Escherichia coli infection
|
Dabigatran Dabigatran 💬Pathogenic Escherichia coli infection
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬14. Pathogenic Escherichia coli infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
F2 1件: F2 💬Pathways in cancer
|
Dabigatran Dabigatran 💬Pathways in cancer
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬15. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
NQO1 1件: NQO1 💬Pathways in cancer
|
Warfarin sodium Warfarin sodium 💬Pathways in cancer
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬16. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
NQO1 1件: NQO1 💬Pathways in cancer
|
Warfarin potassium Warfarin potassium 💬Pathways in cancer
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬16. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
NQO1 1件: NQO1 💬Pathways in cancer
|
Warfarin Warfarin 💬Pathways in cancer
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬16. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
F2 1件: F2 💬Phospholipase D signaling pathway
|
Dabigatran Dabigatran 💬Phospholipase D signaling pathway
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬19. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
F2 1件: F2 💬Platelet activation
|
Dabigatran Dabigatran 💬Platelet activation
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬20. Platelet activation
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
F2 1件: F2 💬Regulation of actin cytoskeleton
|
Dabigatran Dabigatran 💬Regulation of actin cytoskeleton
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬21. Regulation of actin cytoskeleton
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 3 drugs (DrugBank) and 15 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin sodium Warfarin sodium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 3 drugs (DrugBank) and 15 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin potassium Warfarin potassium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 3 drugs (DrugBank) and 15 diseases |
NQO1 2件: NQO1, VKORC1 💬
|
Warfarin Warfarin 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 12件: 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Complement and coagulation cascades
22 genes, 45 drugs (DrugBank) and 52 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Hepatocellular carcinoma
21 genes, 32 drugs (DrugBank) and 67 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
Platelet activation
25 genes, 67 drugs (DrugBank) and 64 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Ubiquinone and other terpenoid-quinone biosynthesis
3 genes, 3 drugs (DrugBank) and 15 diseases